{"id":"cipros-10-association","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Tendinopathy"},{"rate":null,"effect":"QT prolongation"},{"rate":null,"effect":"Photosensitivity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cipros 10 association combines ciprofloxacin, a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, with a complementary agent to broaden spectrum or improve therapeutic outcomes. The exact composition of the 'association' component is not clearly documented in standard pharmaceutical databases, limiting precise mechanistic characterization.","oneSentence":"Cipros 10 association is a fixed-dose combination of ciprofloxacin and an additional agent designed to enhance antimicrobial efficacy.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:05:59.101Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (specific indications not clearly defined in available data)"}]},"trialDetails":[{"nctId":"NCT03527069","phase":"PHASE3","title":"Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment","status":"COMPLETED","sponsor":"EMS","startDate":"2021-01-29","conditions":"Hypertriglyceridemia, Dyslipidemia","enrollment":146}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["EMS association"],"phase":"phase_3","status":"active","brandName":"Cipros 10 association","genericName":"Cipros 10 association","companyName":"EMS","companyId":"ems","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cipros 10 association is a fixed-dose combination of ciprofloxacin and an additional agent designed to enhance antimicrobial efficacy. Used for Bacterial infections (specific indications not clearly defined in available data).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}